Nova R Wealth, Inc. Novo Cure LTD Transaction History

Nova R Wealth, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	SELL	$40.29 - $82.51 $5,640 - $11,551	-140 Reduced 2.03%	6,761 $280,000
Q1 2023 Apr 17, 2023	SELL	$56.44 - $118.81 $169 - $356	-3 Reduced 0.04%	6,901 $415,000
Q4 2022 Jan 31, 2023	SELL	$63.98 - $85.37 $13,563 - $18,098	-212 Reduced 2.98%	6,904 $506,000
Q3 2022 Oct 25, 2022	SELL	$67.99 - $89.57 $1,087 - $1,433	-16 Reduced 0.22%	7,116 $541,000
Q2 2022 Jul 15, 2022	BUY	$56.6 - $89.9 $10,697 - $16,991	189 Added 2.72%	7,132 $496,000
Q1 2022 May 10, 2022	BUY	$60.15 - $84.52 $64,721 - $90,943	1,076 Added 18.34%	6,943 $575,000
Q4 2021 Jan 27, 2022	BUY	$75.08 - $121.99 $440,494 - $715,715	5,867 New	5,867 $440,000

263

76.9M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.76B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Nova R Wealth, Inc., based on Form 13F filings with the SEC.

Stay updated on Nova R Wealth, Inc. with notifications on news.